SCHEMBL312252

SCHEMBL312252

CCOC(=O)Cc1cc(O)ccc1-c1cc(=O)c2cc(O)c(O)cc2o1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1B1 P15121 2/20 0.46
HPGD P15428 7/20 0.45
KDM4E B2RXH2 7/20 0.45
ALDH1A1 P00352 5/20 0.45
MEN1 O00255 4/20 0.45
KMT2A Q03164 4/20 0.45
GAA P10253 4/20 0.45
MAPT P10636 3/20 0.45
POLB P06746 2/20 0.45
BLM P54132 2/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
ALOX12 P18054 2/20 0.45
AKR1B10 O60218 1/20 0.45
USP2 O75604 1/20 0.45
ABL1 P00519 1/20 0.45
PKM P14618 1/20 0.45
MPI P34949 1/20 0.45
RECQL P46063 1/20 0.45
MCL1 Q07820 1/20 0.45
RIN1 Q13671 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL312410 0.91 CYP3A4 (0.52) AKR1B1HPGDKDM4EALDH1A1MEN1
SCHEMBL312740 0.91 AKR1B1 (0.57) AKR1B1HPGDKDM4EALDH1A1MEN1
SCHEMBL10215485 0.87 HPGD (0.59) AKR1B1HPGDKDM4EALDH1A1MEN1
SCHEMBL311334 0.84 EGFR (0.46) HPGDKDM4EALDH1A1KMT2AGAA
SCHEMBL312442 0.84 BACE1 (0.62) AKR1B1HPGDKDM4EALDH1A1MEN1
SCHEMBL311402 0.84 ATM (0.53) HPGDKDM4EALDH1A1MEN1KMT2A
SCHEMBL311828 0.83 CYP2D6 (0.46) AKR1B1HPGDKDM4EALDH1A1MEN1
SCHEMBL311962 0.80 EGFR (0.47) HPGDKDM4EALDH1A1MEN1KMT2A
SCHEMBL312029 0.80 HPGD (0.47) AKR1B1HPGDKDM4EALDH1A1MEN1
SCHEMBL311784 0.80 AKR1B1 (0.46) AKR1B1HPGDKDM4EALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8093273-B2 Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2012-01-10 US disclosed
EP-2332527-A2 Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases RESVERLOGIX CORP. (CA) 2011-06-15 EP disclosed